Roche, Eli Lilly
Eli Lilly lowered the price of two dosage levels of its weight-loss drug Zepbound for patients paying out of pocket. The company also launched new 7.5-mg and 10-mg single-use vials, which ...
Eli Lilly & Co. said Tuesday it’s cutting the ... a regulatory ruling that there’s no longer a shortage of weight-loss drugs that had allowed for alternatives to be made, sending the stock ...
The weight-loss drug boom has transformed Eli Lilly (LLY), the maker of Zepbound, into the largest healthcare company in the world. Now, the pharma giant wants to reinvest its success with ...
New pricing aims to attract cash-paying customers via LillyDirect Hims & Hers warns it may stop selling compounded version of Novo Nordisk weight-loss ... drug, according to analysts. Eli ...
Eli Lilly LLY-0.69%decrease; red down pointing triangle is expanding its offerings of its hit weight-loss drug Zepbound for people who want to pay cash instead of using their health plans ...
Eli Lilly's weight-loss drugs include Mounjaro and Zepbound.Sandy Huffaker for The Washington Post/Getty Images Weight-loss drugs such as Ozempic and Zepbound cost $900 to $1,500 for a ...
"Eli Lilly Introduces New Weight Loss Drug Doses, Lowers Price Points," at 7:21 a.m. incorrectly said Zepbound also comes in 10 and 12.5 milligram vials. About Dow Jones Newswires Dow Jones ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback